share_log
  • Headlines
  • hualan biological engineering, inc. (002007.SZ) released its performance for the first three quarters, with a net income of 0.924 billion yuan, a year-on-year decrease of 13.46%.

华兰生物(002007.SZ)发布前三季度业绩，净利润9.24亿元，同比下降13.46%

hualan biological engineering, inc. (002007.SZ) released its performance for the first three quarters, with a net income of 0.924 billion yuan, a year-on-year decrease of 13.46%.

Zhitong Finance ·  Oct 29, 2024 23:20

Hualan Biological Engineering, Inc. (002007.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...

Zhixin Finance and Economics APP News, Hualan Biological Engineering, Inc. (002007.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue of 3.491 billion yuan, a year-on-year decrease of 10.79%. The net income attributable to shareholders of the listed company was 0.924 billion yuan, a year-on-year decrease of 13.46%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.817 billion yuan, a year-on-year decrease of 9.75%.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Gan & Lee Pharmaceuticals.
    603087
    -- 45.36
    Sunshine Guojian Pharmaceutical
    688336
    -- 22.61
    Shanghai OPM Biosciences
    688293
    -- 43.53
    BHGB
    833575
    -- 18.45
    Beijing Wantai Biological Pharmacy Enterprise
    603392
    -- 69.38
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Big Tech’s earnings season in full swing! Nvidia is the only one left
    On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
    AMZN earnings preview: Grab rewards by guessing the opening price!